Showing results (161-170 of 373) with videos related to
Sort By:
Pageof 38
Journal of Clinical Microbiology|December 1, 1992
Cellular fatty acids in Fusobacterium species as a tool for identificationK Tunér, E J Baron, P Summanen, et al.The Journal of Antimicrobial Chemotherapy|March 27, 2001
In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteriaH M Wexler, E Molitoris, D Molitoris, et al.FEMS Immunology and Medical Microbiology|March 1, 1993
The importance of black-pigmented gram-negative anaerobes in human infectionsS M Finegold, C A Strong, M McTeague, et al.The Journal of Antimicrobial Chemotherapy|October 1, 1994
In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteriaH M Wexler, E Molitoris, D Reeves, et al.Antimicrobial Agents and Chemotherapy|October 1, 1994
In vitro activity of DU-6859a against anaerobic bacteriaH M Wexler, E Molitoris, D Reeves, et al.Journal of Clinical Microbiology|March 1, 1981
Rapid method that aids in distinguishing Gram-positive from Gram-negative anaerobic bacteriaS Halebian, B Harris, S M Finegold, et al.Journal of Clinical Microbiology|July 1, 1979
Rapid presumptive bacteriological diagnosis of Legionnaires diseaseS Faine, P Edelstein, B D Kirby, et al.Antimicrobial Agents and Chemotherapy|September 1, 1996
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteriaH M Wexler, E Molitoris, D Molitoris, et al.The Journal of Antimicrobial Chemotherapy|December 1, 1991
In-vitro activity of temafloxacin against anaerobic bacteria: a comparative studyS M Finegold, E Molitoris, D Reeves, et al.Antimicrobial Agents and Chemotherapy|April 29, 1998
In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infectionsH M Wexler, E Molitoris, D Molitoris, et al.Pageof 38